210 related articles for article (PubMed ID: 18800610)
1. [Targeted therapies for lung cancer].
Tamura K
Rinsho Ketsueki; 2008 Aug; 49(8):616-21. PubMed ID: 18800610
[No Abstract] [Full Text] [Related]
2. [From ASCO and WCLC 2005 to the clinical practice: targeted therapies].
PĂ©rol M
Rev Pneumol Clin; 2006 Feb; 62 Spec no 1():1S30-4. PubMed ID: 16719154
[No Abstract] [Full Text] [Related]
3. [Tyrosine kinase inhibitors in tumor therapy--part 2. Current position and perspectives].
Grimm CF; Blum HE; Geissler M
Dtsch Med Wochenschr; 2005 Jun; 130(23):1438-42. PubMed ID: 15929020
[No Abstract] [Full Text] [Related]
4. Targeted therapies in the treatment of advanced non-small-cell lung cancer: update.
Mendoza L
Klin Onkol; 2009; 22(4):131-8. PubMed ID: 19731875
[TBL] [Abstract][Full Text] [Related]
5. Targeted therapy in advanced non-small cell lung cancer (NSCLC): where do we stand?
Azim HA; Ganti AK
Cancer Treat Rev; 2006 Dec; 32(8):630-6. PubMed ID: 17034953
[TBL] [Abstract][Full Text] [Related]
6. The emerging role of vascular endothelial growth factor receptor tyrosine kinase inhibitors.
Langer CJ; Natale RB
Semin Oncol; 2005 Dec; 32(6 Suppl 10):S23-9. PubMed ID: 16459176
[TBL] [Abstract][Full Text] [Related]
7. Lung cancer: looking ahead in 2004.
Belani CP; Ramalingam S
Clin Lung Cancer; 2004 Jan; 5(4):200. PubMed ID: 14967070
[No Abstract] [Full Text] [Related]
8. The rational basis of using novel targeted biological agents in non-small cell lung cancer.
Ciardiello F
Suppl Tumori; 2002; 1(4):S31-3. PubMed ID: 12415813
[No Abstract] [Full Text] [Related]
9. Developing targeted therapies for lung cancer.
Gandara DR
Clin Adv Hematol Oncol; 2003 Nov; 1(11):648-9, 690. PubMed ID: 16258461
[No Abstract] [Full Text] [Related]
10. [The actual place of anti-angiogenesis in non-small cell lung cancer].
Mennecier B
Rev Mal Respir; 2007 Oct; 24(8 Pt 2):6S198-205. PubMed ID: 18235414
[TBL] [Abstract][Full Text] [Related]
11. Economics and the new generation of targeted therapies for non-small cell lung cancer.
Ramsey SD
J Natl Cancer Inst; 2010 Mar; 102(5):287-8. PubMed ID: 20160167
[No Abstract] [Full Text] [Related]
12. Bevacizumab in non small cell lung cancer.
Sandler A
Clin Cancer Res; 2007 Aug; 13(15 Pt 2):s4613-6. PubMed ID: 17671151
[TBL] [Abstract][Full Text] [Related]
13. Using EGFR status to personalize treatment: lung cancer researchers reach a milestone.
Friedrich MJ
J Natl Cancer Inst; 2009 Aug; 101(15):1039-41. PubMed ID: 19638503
[No Abstract] [Full Text] [Related]
14. Benefits and limitations of antiangiogenic agents in patients with non-small cell lung cancer.
Bertino EM; Otterson GA
Lung Cancer; 2010 Dec; 70(3):233-46. PubMed ID: 20888062
[TBL] [Abstract][Full Text] [Related]
15. Clinical implications of EGFR expression in the development and progression of solid tumors: focus on non-small cell lung cancer.
Ettinger DS
Oncologist; 2006 Apr; 11(4):358-73. PubMed ID: 16614231
[TBL] [Abstract][Full Text] [Related]
16. Unusual cases in multiple myeloma and a dramatic response in metastatic lung cancer: case 4. Mutation of the epidermal growth factor receptor in an elderly man with advanced, gefitinib-responsive, non-small-cell lung cancer.
Cho D; Kocher O; Lee JC; Tenen DG; Meyerson ML; Janne PA; Halmos B
J Clin Oncol; 2005 Jan; 23(1):235-7. PubMed ID: 15625379
[No Abstract] [Full Text] [Related]
17. Targeting the epidermal growth factor receptor a new strategy in cancer treatment.
Gianni L; Grasselli G
Suppl Tumori; 2002; 1(4):S60-1. PubMed ID: 12415824
[No Abstract] [Full Text] [Related]
18. [New advance of the molecular targeting agents in advanced non-small cell lung cancer].
Zhang L; Cheng ZW; Gao JM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):323-9. PubMed ID: 15266840
[TBL] [Abstract][Full Text] [Related]
19. Targeted therapies for non-small-cell lung cancer: biology, rationale, and preclinical results from a radiation oncology perspective.
Raben D; Helfrich B; Bunn PA
Int J Radiat Oncol Biol Phys; 2004; 59(2 Suppl):27-38. PubMed ID: 15142632
[TBL] [Abstract][Full Text] [Related]
20. [Angiogenesis and metastasis in colorectal cancer].
Yamada K; Yamamura T; Yamaguchi S
Nihon Rinsho; 2003 Sep; 61 Suppl 7():97-101. PubMed ID: 14574863
[No Abstract] [Full Text] [Related]
[Next] [New Search]